Ishita Drugs & Industries standalone net profit declines 9.52% in the September 2024 quarter
Net profit of Ishita Drugs & Industries declined 9.52% to Rs 0.19 crore in the quarter ended September 2024 as against Rs 0.21 crore during the previous quarter ended September 2023. Sales declined 25.68% to Rs 3.27 crore in the quarter ended September 2024 as against Rs 4.40 crore during the previous quarter ended September 2023.
Particulars | Quarter Ended | ||
Sep. 2024 | Sep. 2023 | % Var. | |
Sales | 3.27 | 4.40 | -26 |
OPM % | 7.03 | 5.00 | - |
PBDT | 0.28 | 0.31 | -10 |
PBT | 0.25 | 0.28 | -11 |
NP | 0.19 | 0.21 | -10 |
Top Jewellery Stocks in India
13 mins read . Nov 19, 2024
List of Stock Exchanges in India
16 mins read . Nov 19, 2024
Hindustan Unilever History
14 mins read . Nov 8, 2024
Explore our products
₹0 Brokerage *
Open Demat Account